User Fee “Reverse Trigger” Added To House FDA Reform Bill
This article was originally published in The Pink Sheet Daily
Executive SummaryAdditional fees for postmarketing activity would not be assessed if funds were appropriated from general revenue.
You may also be interested in...
Limits On Pediatric Exclusivity And DTC Advertising Stripped From FDA Bill During Subcommittee Markup
Association for Accessible Medicines’ interim leader is General Counsel Jeffrey Francer; Chip Davis’ four-and-half year tenure included a total rebrand of the association, a significant legislative victory with the CREATES act – and an abrupt departure for the Healthcare Distribution Alliance.